Home / Stocks / BERLDRG
Back to all stocks
BSE · BERLDRG

Beryl Drugs Ltd. (BERLDRG) Share Price

Sector: Healthcare · ISIN: INE415H01017

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,445
of 5,047 stocks
▼ 521W→ 01M
Peak #4,344 · 02 Oct 2026

Beryl Drugs Ltd., a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and has a widely-held ownership base, with promoters at just 28%. Ownership as of Jun 2026.

Market Cap
12.47 Cr
P/E Ratio
81.97
P/B Ratio
1.26
ROE
4.30%
ROCE
8.94%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ1 2026-27Q4 2025-26Q3 2025-26Q2 2025-26
Revenue7.30 Cr5.13 Cr3.78 Cr5.12 Cr
Net Profit22.08 L56.25 L-16.77 LRs 89,000
EPS0.441.11-0.330.02
Operating Profit33.18 L93.73 L-51.61 L34.05 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
27.82%
Public
72.18%

PUBLIC BREAKDOWN

Individuals
67.62%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
23 Aug 2002DividendNIL Dividend - Rs. - 0.0000

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs